IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Novasep completes expansion of HPAPI capacity in France

4:04 AM MDT | May 22, 2014 | Deepti Ramesh

Novasep (Pompey, France), a supplier of services and technologies to the life sciences industry, says that it has completed a €4-million ($5.5 million) expansion of its highly potent active pharmaceutical ingredient (HPAPI) manufacturing capabilities at the company’s facility at Le Mans, France. The plant expansion has been fully qualified and is now being used to scale up validation of a commercial antibody-drug conjugate (ADC) payload, Novasep says. ADCs offer a new treatment method for cancer under which cancer cells are destroyed in a more targeted...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa